LGALS3 and Hyperglycemia: Since galectin-3 was demonstrated to be involved in inflammatory and fibrotic processes as well as cardiac remodeling15,16, we hypothesized that galectin-3 might be a specific and complementary biomarker particularly for hyperglycaemia induced cardiac impairment.